-
Je něco špatně v tomto záznamu ?
Functional polymorphisms of the receptor for the advanced glycation end product promoter gene in inflammatory bowel disease: a case-control study
R. Ciccocioppo, S. Bozzini, E. Betti, V. Imbesi, C. Klersy, LS. Lakyova, L. Sukovsky, J. Benacka, P. Kruzliak, GR. Corazza, A. Di Sabatino, C. Falcone,
Jazyk angličtina Země Itálie
Typ dokumentu časopisecké články
- MeSH
- dospělí MeSH
- frekvence genu MeSH
- genetická predispozice k nemoci * MeSH
- genotyp MeSH
- genotypizační techniky MeSH
- idiopatické střevní záněty genetika MeSH
- jednonukleotidový polymorfismus * MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- polymorfismus délky restrikčních fragmentů MeSH
- prevalence MeSH
- promotorové oblasti (genetika) * MeSH
- receptor pro konečné produkty pokročilé glykace genetika MeSH
- studie případů a kontrol MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
The receptor for the advanced glycation end products (RAGE) is a multiligand transmembrane receptor involved in chronic inflammation whose specific polymorphisms of the promoter gene were found to increase its transcriptional activity. We investigated the association of both allelic and genotypic -374T/A and -429T/C polymorphisms with inflammatory bowel disease. The STREGA guidelines were applied for planning and reporting. We enrolled 133 patients with Crohn's disease (CD), 149 with ulcerative colitis (UC), and 128 blood donors. Genomic DNA was extracted from peripheral blood leukocytes collected from each patient and control. RAGE polymorphisms were analyzed by PCR-restriction fragment length polymorphism assay. The Hardy-Weinberg equilibrium was first assessed, and then, the Kruskal-Wallis test and the Fisher exact test were used for etiologic group comparisons. Distribution of patients' characteristics across genotypes was evaluated by the Fisher exact test, while that across alleles was analyzed with a probit model. A 2-sided value of p < 0.05 was considered significant. Following the evidence of the Hardy-Weinberg equilibrium, we found a higher prevalence of the allele A of the -374T/A haplotype in UC (p = 0.043), and of the allele C of the -429T/C haplotype in CD (p < 0.001) with respect to the other groups. Moreover, the homozygous AA genotype of the -374T/A polymorphism resulted associated with late onset of CD, while its TT genotype with early onset (p = 0.049). The allele C of the 429T/C haplotype was associated with early onset of UC (p = 0.03), while a higher frequency of the heterozygous TC haplotype was found in those with pancolitis (p = 0.026). The differing distribution of these polymorphisms in healthy donors and CD/UC patients suggests a role in the development and outcome of these pathological conditions.
Faculty of Health and Social Work Trnava University Trnava Slovakia
Gastroenterology and Digestive Endoscopy Unit Legnano Hospital ASST Ovest Milanese Legnano Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19044772
- 003
- CZ-PrNML
- 005
- 20200113110107.0
- 007
- ta
- 008
- 200109s2019 it f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10238-019-00562-x $2 doi
- 035 __
- $a (PubMed)31175506
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Ciccocioppo, Rachele $u Gastroenterology Unit, Department of Medicine, AOUI Policlinico G.B. Rossi and University of Verona, Piazzale L.A. Scuro, 10, 37134, Verona, Italy. rachele.ciccocioppo@univr.it.
- 245 10
- $a Functional polymorphisms of the receptor for the advanced glycation end product promoter gene in inflammatory bowel disease: a case-control study / $c R. Ciccocioppo, S. Bozzini, E. Betti, V. Imbesi, C. Klersy, LS. Lakyova, L. Sukovsky, J. Benacka, P. Kruzliak, GR. Corazza, A. Di Sabatino, C. Falcone,
- 520 9_
- $a The receptor for the advanced glycation end products (RAGE) is a multiligand transmembrane receptor involved in chronic inflammation whose specific polymorphisms of the promoter gene were found to increase its transcriptional activity. We investigated the association of both allelic and genotypic -374T/A and -429T/C polymorphisms with inflammatory bowel disease. The STREGA guidelines were applied for planning and reporting. We enrolled 133 patients with Crohn's disease (CD), 149 with ulcerative colitis (UC), and 128 blood donors. Genomic DNA was extracted from peripheral blood leukocytes collected from each patient and control. RAGE polymorphisms were analyzed by PCR-restriction fragment length polymorphism assay. The Hardy-Weinberg equilibrium was first assessed, and then, the Kruskal-Wallis test and the Fisher exact test were used for etiologic group comparisons. Distribution of patients' characteristics across genotypes was evaluated by the Fisher exact test, while that across alleles was analyzed with a probit model. A 2-sided value of p < 0.05 was considered significant. Following the evidence of the Hardy-Weinberg equilibrium, we found a higher prevalence of the allele A of the -374T/A haplotype in UC (p = 0.043), and of the allele C of the -429T/C haplotype in CD (p < 0.001) with respect to the other groups. Moreover, the homozygous AA genotype of the -374T/A polymorphism resulted associated with late onset of CD, while its TT genotype with early onset (p = 0.049). The allele C of the 429T/C haplotype was associated with early onset of UC (p = 0.03), while a higher frequency of the heterozygous TC haplotype was found in those with pancolitis (p = 0.026). The differing distribution of these polymorphisms in healthy donors and CD/UC patients suggests a role in the development and outcome of these pathological conditions.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a frekvence genu $7 D005787
- 650 12
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a genotypizační techniky $7 D060005
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a idiopatické střevní záněty $x genetika $7 D015212
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a polymorfismus délky restrikčních fragmentů $7 D012150
- 650 12
- $a jednonukleotidový polymorfismus $7 D020641
- 650 _2
- $a prevalence $7 D015995
- 650 12
- $a promotorové oblasti (genetika) $7 D011401
- 650 _2
- $a receptor pro konečné produkty pokročilé glykace $x genetika $7 D000067759
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bozzini, Sara $u Interdipartimental Center for the Molecular Medicine Research and Cardiology Unit, Istituto di Cura Città di Pavia and University of Pavia, Pavia, Italy.
- 700 1_
- $a Betti, Elena $u Clinica Medica I, Department of Internal Medicine and Therapeutics, I.R.C.C.S. Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
- 700 1_
- $a Imbesi, Venerina $u Gastroenterology and Digestive Endoscopy Unit, Legnano Hospital, ASST Ovest Milanese, Legnano, Italy.
- 700 1_
- $a Klersy, Catherine $u Service of Clinical Epidemiology and Biostatistics, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy.
- 700 1_
- $a Lakyova, Lucia Sukovska $u 1st Department of Surgery, Faculty of Medicine, Pavol Jozef Safarik University and Louis Pasteur University Hospital, Trieda SNP1, 040 11, Kosice, Slovakia. lucia.lakyova@upjs.sk.
- 700 1_
- $a Sukovsky, Lukas $u 1st Department of Surgery, Faculty of Medicine, Pavol Jozef Safarik University and Louis Pasteur University Hospital, Trieda SNP1, 040 11, Kosice, Slovakia.
- 700 1_
- $a Benacka, Jozef $u Faculty of Health and Social Work, Trnava University, Trnava, Slovakia.
- 700 1_
- $a Kruzliak, Peter $u Department of Internal Medicine, Brothers of Mercy Hospital, Polni 3, 63900, Brno, Czech Republic. kruzliakpeter@gmail.com. 2nd Department of Surgery, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Brno, Czech Republic. kruzliakpeter@gmail.com.
- 700 1_
- $a Corazza, Gino Roberto $u Clinica Medica I, Department of Internal Medicine and Therapeutics, I.R.C.C.S. Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
- 700 1_
- $a Di Sabatino, Antonio $u Clinica Medica I, Department of Internal Medicine and Therapeutics, I.R.C.C.S. Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy.
- 700 1_
- $a Falcone, Colomba $u Interdipartimental Center for the Molecular Medicine Research and Cardiology Unit, Istituto di Cura Città di Pavia and University of Pavia, Pavia, Italy.
- 773 0_
- $w MED00006222 $t Clinical and experimental medicine $x 1591-9528 $g Roč. 19, č. 3 (2019), s. 367-375
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31175506 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200113110439 $b ABA008
- 999 __
- $a ok $b bmc $g 1483041 $s 1083445
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 19 $c 3 $d 367-375 $e 20190607 $i 1591-9528 $m Clinical and Experimental Medicine $n Clin Exp Med $x MED00006222
- LZP __
- $a Pubmed-20200109